Alcon Inc
ALC- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- SEC CIK
- 0001167379
No open-market purchases or sales by Alcon Inc insiders were filed in the last 90 days; 636 institutions reported holding it in 13F filings for Q2 2026, worth $16.2B in total; Maverick Capital is the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding Alcon Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 563 | 13 | 591 | +41 |
| Shares | 229.6M | 280.8K | 226.6M | −2.66M (−1.2%) |
| Value | $13.4B | $16.4M | $15.2B | +$1.83B (+13.7%) |
13 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (101)
Institutions that held Alcon Inc at the end of Q4 2022 but not at the end of Q3 2022.
Showing the largest 100 of 101 by value.
Sold out (60)
Institutions that held Alcon Inc at the end of Q3 2022 and filed for Q4 2022 without it.
Not filed for Q4 2022 yet (13)
Institutions that held Alcon Inc at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Eaton Vance Management | 217,810 | $12.7M |
| Jefferies Group LLC | 22,100 | $1.29M |
| 17 Capital Partners, LLC | 15,345 | $893.0K |
| Corient Capital Partners, LLC | 6,786 | $474.0K |
| Regentatlantic Capital LLC | 8,133 | $473.0K |
| Bluestein R H & Co | 6,020 | $350.0K |
| Wipfli Financial Advisors LLC, | 2,214 | $129.0K |
| Covington Capital Management | 1,037 | $60.0K |
| American Portfolios Advisors | 692 | $40.8K |
| FourThought Financial, LLC | 424 | $25.0K |
| American Research & Management Co. | 250 | $15.0K |
| Pacific Center for Financial Services | 24 | $1.00K |
| Siena Capital LLC | 6 | $0 |